AC Immune reports positive Phase 2 results for Parkinson's vaccine ACI-7104

September 23, 2026 7:02 AM

AC Immune SA (NASDAQ: ACIU) announced positive safety and immunogenicity results through week 100 in Part 1 of VacSYn, its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found